Hironic Co. Ltd - Asset Resilience Ratio
Hironic Co. Ltd (149980) has an Asset Resilience Ratio of 17.42% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Hironic Co. Ltd carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Hironic Co. Ltd's Asset Resilience Ratio has changed over time. See Hironic Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Hironic Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hironic Co. Ltd asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩13.94 Billion | 17.42% |
| Total Liquid Assets | ₩13.94 Billion | 17.42% |
Asset Resilience Insights
- Good Liquidity Position: Hironic Co. Ltd maintains a healthy 17.42% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hironic Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Hironic Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
|
Brainsway Ltd
NASDAQ:BWAY |
Medical Devices | 0.87% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Hironic Co. Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Hironic Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 17.42% | ₩13.94 Billion ≈ $9.45 Million |
₩80.01 Billion ≈ $54.22 Million |
-1.27pp |
| 2023-12-31 | 18.69% | ₩14.78 Billion ≈ $10.02 Million |
₩79.10 Billion ≈ $53.60 Million |
-17.47pp |
| 2022-12-31 | 36.16% | ₩24.41 Billion ≈ $16.54 Million |
₩67.51 Billion ≈ $45.75 Million |
+3.61pp |
| 2021-12-31 | 32.54% | ₩20.72 Billion ≈ $14.04 Million |
₩63.67 Billion ≈ $43.15 Million |
-8.39pp |
| 2020-12-31 | 40.93% | ₩18.32 Billion ≈ $12.42 Million |
₩44.76 Billion ≈ $30.33 Million |
+6.53pp |
| 2019-12-31 | 34.41% | ₩16.12 Billion ≈ $10.93 Million |
₩46.87 Billion ≈ $31.76 Million |
+10.80pp |
| 2018-12-31 | 23.61% | ₩10.15 Billion ≈ $6.88 Million |
₩43.01 Billion ≈ $29.15 Million |
-18.72pp |
| 2017-12-31 | 42.32% | ₩21.17 Billion ≈ $14.35 Million |
₩50.03 Billion ≈ $33.91 Million |
-7.34pp |
| 2016-12-31 | 49.67% | ₩22.21 Billion ≈ $15.05 Million |
₩44.72 Billion ≈ $30.31 Million |
-1.80pp |
| 2015-12-31 | 51.46% | ₩23.60 Billion ≈ $15.99 Million |
₩45.86 Billion ≈ $31.08 Million |
-16.80pp |
| 2014-12-31 | 68.26% | ₩36.45 Billion ≈ $24.70 Million |
₩53.40 Billion ≈ $36.19 Million |
-- |
About Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.